Health officials in San Francisco and Alameda counties have cut ties with Verily’s state-funded COVID testing sites amid concerns about data collection and privacy.
Poor information-sharing between hospitals and public health agencies has hurt the response to the pandemic. Some health care systems and IT companies are making inroads, but an overhaul would cost billions.
The coronavirus pandemic has forced the nation’s doctors and hospitals to reevaluate how they work. At least three major changes may have a lasting impact.
The pandemic offers an opportunity to use artificial intelligence programs to help doctors in COVID-19 diagnosis. But some leading hospital systems have shelved their AI technology because it wasn’t ready to roll.
The U.S. government spent $36 billion computerizing health records, yet they’re of limited help in the COVID-19 crisis.
HHS said this test would “save personal protective equipment.” But Abbott’s very design ― devised for mobile testing — means those working with specimens need even more protection, experts warn.
Under the national emergency, the government has waived a law that required patients to have an in-person visit with a physician before they could be prescribed drugs that help quell withdrawal symptoms, such as Suboxone. Now they can get those prescriptions via a phone call or videoconference with a doctor. That may give video addiction therapy a kick-start.
“Unscrupulous providers” could take advantage of the boom in treatment delivered via voice or video calls.
With hospitals struggling to get more ventilators, they must ensure every ventilator they have is ready for service. But manufacturers limit who can repair them.
Big data plays a critical role in the success of current public health efforts to control the spread of the coronavirus. Privacy advocates, though, are watching closely.